August 28, 2025 First Generic GLP-1 for Weight Loss Approved FDA approves Teva’s generic Saxenda (liraglutide) with adult and adolescent indications and a boxed thyroid tumor warning. Conexiant
August 28, 2025 PeakClimber: An Open-Source Solution for Smarter HPLC Peak Analysis The Analytical Scientist
August 28, 2025 PeakClimber: An Open-Source Solution for Smarter HPLC Peak Analysis The Analytical Scientist
August 18, 2025 Study Finds GLP-1RAs May Lower Risk of Obesity-Related Cancers vs DPP-4 Inhibitors in Adults With Diabetes and Obesity The ASCO Post
June 25, 2025 Menopause Medication May Help to Prevent Invasive Breast Cancer, Study Finds The ASCO Post
June 16, 2025 Vepdegestrant Improves Progression-Free Survival in Select Patients With ESR1-Mutant Advanced Breast Cancer The ASCO Post
August 22, 2025 Patient Awareness of Pharmacogenomic Testing Remains Low, ACS CAN Survey Reports The ASCO Post
August 22, 2025 New Recommendations Released for Managing Aromatase Inhibitor–Induced Bone Loss The ASCO Post
August 22, 2025 Avutometinib Plus Defactinib in Recurrent Low-Grade Serous Ovarian Cancer The ASCO Post
June 10, 2024 How the Museum of Medicine and Biomedical Discovery Aims to Bring Scientific Achievements of the Past, Present, and Future to Life The ASCO Post